ETHZilla Raises $156M to Amplify Ethereum Holdings

Publicly traded ETHZilla, formerly 180 Life Sciences Corp., has secured a significant $156 million in funding through convertible notes. This investment will be primarily used to expand its already considerable Ethereum holdings. The company’s strategy announcement on August 11, 2025, signals a growing trend of public companies investing in cryptocurrencies and potentially influencing the Ethereum market landscape.